To access this element change to forms mode OFF
Grant Award View - GA217902
The AIRSPACE Trial: AntI-MRSA PhAge Cocktail treatment via Acoustic...
GA ID:
GA217902
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2026
Value (AUD):
$1,712,340.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
The AIRSPACE Trial: AntI-MRSA PhAge Cocktail treatment via Acoustic Enhanced Nebulisers
Purpose:
Previous research in our team has shown promise for the use of bacteriophage, a virus that kills bacteria, for the treatment of infections of the sinuses. However, delivery of bacteriophage to the sinuses uses a nasal rinsing device, wasting >97% of phage. This is unacceptable as manufacturing of phage is expensive. In this project we will conduct a trial to see whether treatments with bacteriophage delivered using a specific device is more effective than antibiotics to kill those bacteria.
GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2014977
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
Adelaide
Town/City:
Adelaide
Postcode:
5000
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
Country:
AUSTRALIA